The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury.

[1]  M. Ranalli,et al.  IL‐25 prevents and cures fulminant hepatitis in mice through a myeloid‐derived suppressor cell‐dependent mechanism , 2013, Hepatology.

[2]  Xiaofeng Han,et al.  CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice[S] , 2013, Journal of Lipid Research.

[3]  S. Friedman,et al.  CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin‐10 in mice , 2012, Hepatology.

[4]  A. Nakamura,et al.  Regulation of plasmacytoid dendritic cell responses by PIR-B. , 2012, Blood.

[5]  C. Selmi,et al.  The immunopathology of liver granulomas in primary biliary cirrhosis. , 2012, Journal of autoimmunity.

[6]  Q. Wang,et al.  Interleukin‐17 exacerbates hepatic steatosis and inflammation in non‐alcoholic fatty liver disease , 2011, Clinical and experimental immunology.

[7]  A. Nakamura,et al.  Transcriptional Activation of the Pirb Gene in B Cells by PU.1 and Runx3 , 2011, The Journal of Immunology.

[8]  S. Strittmatter,et al.  Differential but Competitive Binding of Nogo Protein and Class I Major Histocompatibility Complex (MHCI) to the PIR-B Ectodomain Provides an Inhibition of Cells* , 2011, The Journal of Biological Chemistry.

[9]  M. Nagarkatti,et al.  Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol , 2011, PloS one.

[10]  C. Divino,et al.  Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. , 2011, Immunity.

[11]  J. Fung,et al.  Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice , 2011, Hepatology.

[12]  T. Ratliff,et al.  In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site , 2011, European journal of immunology.

[13]  Ian Blumenthal,et al.  Type 1 T Helper Cells Induce the Accumulation of Myeloid‐Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver , 2010, Hepatology.

[14]  L. Denson,et al.  Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. , 2010, Gastroenterology.

[15]  J. Magarian Blander,et al.  Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function , 2010, The Journal of experimental medicine.

[16]  M. Manns,et al.  Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor , 2009, Hepatology.

[17]  D. Lopez,et al.  The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. , 2009, Cancer research.

[18]  P. Sinha,et al.  Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.

[19]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[20]  B. M. Forman,et al.  Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response , 2008, Hepatology.

[21]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[22]  D. Foell,et al.  Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1 , 2008, The Journal of Immunology.

[23]  A. Nakamura,et al.  Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells , 2008, Proceedings of the National Academy of Sciences.

[24]  M. Manns,et al.  A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. , 2008, Gastroenterology.

[25]  P. De Baetselier,et al.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.

[26]  J. Leips,et al.  Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. , 2007, Cancer research.

[27]  P. Edwards,et al.  Regulation of the Sodium/Sulfate Co-transporter by Farnesoid X Receptor α* , 2007, Journal of Biological Chemistry.

[28]  P. Sinha,et al.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. , 2007, Cancer research.

[29]  A. Floreani,et al.  Activation of the IGF1 System Characterizes Cholangiocyte Survival During Progression of Primary Biliary Cirrhosis , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  R. C. van der Veen,et al.  Mycobacteria‐induced Gr‐1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion , 2007, Journal of leukocyte biology.

[31]  C. Muller,et al.  Nuclear receptors in human immune cells: expression and correlations. , 2007, Molecular immunology.

[32]  S. Kliewer,et al.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Leips,et al.  Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression1 , 2006, The Journal of Immunology.

[34]  M. Lutz,et al.  Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro , 2005, European journal of immunology.

[35]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[36]  T. Kawamoto,et al.  A method for preparing 2- to 50-µm-thick fresh-frozen sections of large samples and undecalcified hard tissues , 2000, Histochemistry and Cell Biology.